Abstract

Article15 January 1998free access Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1 Lilian Wikström Lilian Wikström Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Catarina Johansson Catarina Johansson Department of Physiology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Carmen Saltó Carmen Saltó Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Carrolee Barlow Carrolee Barlow Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Angel Campos Barros Angel Campos Barros Laboratory of Genetic Disease Research, NIH, Building 49/4A67, Bethesda, MD, 20892-4470 USA Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, 10029 USA Search for more papers by this author Frank Baas Frank Baas Department of Neurology, Academic Medical Center, University of Amsterdam, The Netherlands Search for more papers by this author Douglas Forrest Douglas Forrest Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, 10029 USA Search for more papers by this author Peter Thorén Peter Thorén Department of Physiology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Björn Vennström Corresponding Author Björn Vennström Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Lilian Wikström Lilian Wikström Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Catarina Johansson Catarina Johansson Department of Physiology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Carmen Saltó Carmen Saltó Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Carrolee Barlow Carrolee Barlow Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Angel Campos Barros Angel Campos Barros Laboratory of Genetic Disease Research, NIH, Building 49/4A67, Bethesda, MD, 20892-4470 USA Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, 10029 USA Search for more papers by this author Frank Baas Frank Baas Department of Neurology, Academic Medical Center, University of Amsterdam, The Netherlands Search for more papers by this author Douglas Forrest Douglas Forrest Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, 10029 USA Search for more papers by this author Peter Thorén Peter Thorén Department of Physiology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Björn Vennström Corresponding Author Björn Vennström Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden Search for more papers by this author Author Information Lilian Wikström1, Catarina Johansson2, Carmen Saltó1, Carrolee Barlow1, Angel Campos Barros3,4, Frank Baas5, Douglas Forrest4, Peter Thorén2 and Björn Vennström 1 1Department of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden 2Department of Physiology, Karolinska Institute, S-17177 Stockholm, Sweden 3Laboratory of Genetic Disease Research, NIH, Building 49/4A67, Bethesda, MD, 20892-4470 USA 4Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, 10029 USA 5Department of Neurology, Academic Medical Center, University of Amsterdam, The Netherlands ‡C.Saltó and C.Barlow contributed equally to this work *Corresponding author. E-mail: [email protected] The EMBO Journal (1998)17:455-461https://doi.org/10.1093/emboj/17.2.455 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Thyroid hormone, acting through several nuclear hormone receptors, plays important roles in thermogenesis, lipogenesis and maturation of the neonatal brain. The receptor specificity for mediating these effects is largely unknown, and to determine this we developed mice lacking the thyroid hormone receptor TRα1. The mice have an average heart rate 20% lower than that of control animals, both under normal conditions and after thyroid hormone stimulation. Electrocardiograms show that the mice also have prolonged QRS- and QTend-durations. The mice have a body temperature 0.5°C lower than normal and exhibit a mild hypothyroidism, whereas their overall behavior and reproduction are normal. The results identify specific and important roles for TRα1 in regulation of tightly controlled physiological functions, such as cardiac pacemaking, ventricular repolarisation and control of body temperature. Introduction Thyroid hormone (TH) is involved in the regulation of many physiological and developmental processes (Forrest 1994; Freake and Oppenheimer 1995; Silva 1995). The hormone (tri-iodothyronine, T3, and its precursor thyroxine, T4) also plays a major role in the cardiovascular system, such as regulation of heart rate, cardiac output and lipid content. Hypothyroidism in man and in animal models manifests in low heart rate and cardiac output as well as hyperlipidemia. In contrast, hyperthyroidism is associated with tachycardia that can lead to arrhythmia, elevated cardiac output and hypolipidemia (Dillman, 1996). Thyroid hormone acts through nuclear hormone receptors (TRs), which are ligand dependent transcription factors encoded by two different genes in mammals, each one giving rise to variant proteins (Lazar et al. 1988; Mitsuhashi et al. 1988). The proteins from the TRα gene have distinct properties: TRα1 binds TH and thereby regulates target gene expression, whereas TRα2 binds no known hormone. Its function is unclear, although it has been suggested that it represses TRα1 functions (Koenig et al. 1989; Katz et al. 1995). Both variant TRβ proteins bind TH and transactivate target genes although they differ in their N-terminal regions. The role of TRβ in mediating the effects of TH has been elucidated in part. The syndrome of generalized resistance to thyroid hormones (GRTH) is well characterized (Refetoff et al. 1993; Refetoff 1994) and has given important clues to the role of TRβ. The syndrome is associated with two different genetic abnormalities, both afflicting the TRβ gene. Heterozygous patients from ∼50 families with a transdominant negative version of the receptor often suffer from elevated levels of TH, growth and mental retardation, tachycardia and attention deficity/hyperactivity. They have surprisingly normal levels of thyroid stimulating hormone (TSH), resulting from the inability of the mutant receptor to downregulate the TSH genes. Moreover, patients and mice lacking the TRβ gene have a hearing loss and have elevated levels of thyroid hormones and TSH (Refetoff et al. 1967; Usala et al. 1991; Takeda et al. 1992; Forrest et al. 1996a, b). The studies suggest that TRβ regulates expression of the pituitary hormones TSH and growth hormone, and that TRβ is important for certain neuronal functions. To clarify the difference between expression of a dominant-negative receptor to that of loss of a receptor, and to determine the roles of the individual thyroid hormone receptors in development, we generated mice with a null mutation of the TRα1 locus using homologous recombination. Our results define, for the first time, specific roles for TRα in mediating the effects of TH. Results Generation of mice lacking TRα1 To determine the roles of the individual TRs in mediating the effects of TH, we wished to develop transgenic mice from which a functional TRα1 gene was deleted, but which still expressed the splice variant, TRα2, and the related orphan receptor, rev-erbAα, that is transcribed on the opposite strand (Lazar et al. 1988, 1989; Miyajima et al. 1989) (Figure 1A). For this we constructed a targeting vector that would replace the TRα1-specific coding sequence with that of TRα2 (Figure 1A). Homologous recombination, which deleted the TRα1-specific sequence in mouse embryonal stem (ES) cells was achieved in three independent cell clones. A detailed Southern blot analysis with 5′, 3′ and internal probes shows that the DNA in one of the ES clones contained no modifications other than those of the desired recombination event (Figure 1B; for details see Materials and methods). Figure 1.Targeting of the TRα locus. (A) shows the structure of the 3′-end of the TRα1/rev-erbAα locus with the targeting vector at bottom. Only the restriction sites relevant for the analysis of the recombination event are shown. The approximate locations for three of the probes used in Southern blotting are shown in boxes. 5′p: 5′ probe; int: internal probe for the 5′ half of the recombined allele; ex10: exon 10 probe. The location of the 3′ probe is not shown for space reasons. Broken lines indicate splicing events. Splice donor sites are indicated by S.D., acceptor sites by S.A. (B) shows a Southern blot analysis of the recombination event in ES cells. DNA from G418 resistant clones was digested with the indicated enzymes. The filters were hybridized, stripped and rehybridized with 5′, 3′ and internal probes as shown in the figure. Odd-numbered lanes show DNA from targeted cells, even-numbered lanes indicate normal cells' DNA. The open arrowhead indicates the location of the normal allele. (C) is a Southern blot analysis of BamHI digested DNA from the progeny of one representative litter from a cross between heterozygotes. The 5′ probe was used for hybridization. The open arrowhead indicates the location of the normal allele, the filled arrowhead shows the mutated gene. (D) shows a RT–PCR analysis of polyadenylated brain RNA from −/−, +/− and −/− mice. The primer pairs chosen detect the RNAs for wt TRα1, TRα2 and targeted TRα2, respectively. The RNA transcribed from the targeted allele is indicated by TRα2t. The sizes of the electrophoresed products correspond to the expected sizes. (E) is a Northern blot of polyadenylated brain RNA. The cDNA probe used for hybridization contained sequences common to all forms of TRα RNAs. The TRα2 RNA from the −/− animals migrated faster than the corresponding RNA from the control animals, due to its shorter 3′ untranslated region originating from SV40 sequences in the targeted allele (see panel A). Download figure Download PowerPoint To learn if the deletion of TRα1 affected viability, heterozygous offspring from founder animals chimeric for the targeted ES cells were mated, and their progeny tested by Southern analyses (Figure 1C). The targeted TRα1 gene was inherited in a Mendelian fashion: crosses between heterozygous female and male mice have given 25 +/+, 46 +/− and 25 −/− animals, with a 50:50 ratio between female and male offspring. This suggests that there is no lethality in −/− embryos. Homozygous animals are viable and survive to at least 18 months of age. Both female and male TRα1 −/− animals were fertile, and the resulting litter sizes were normal. Overall, the animals appear healthy, with no overt abnormalities detected at autopsy. Next, we wished to establish that expression of TRα2 was unaffected by the TRα1 targeting. RNA from the brains of adult mice of the three genotypes was subjected to RT–PCR analyses. In all three instances, the upstream 5′ primer was complementary to sequences in exon 9a, common to all RNAs. The downstream primers annealed to 3′ untranslated sequences specific to TRα1, wild-type (wt) TRα2, or to targeted TRα2. The results demonstrate that products of the expected lengths were found in the respective samples (Figure 1D). Furthermore, the data confirm the absence of TRα1 RNA in the −/− mice. A Northern blot analysis of polyadenylated RNAs substantiates the above results (Figure 1E) and shows that +/− animals contained ∼50% of the level of TRα1 RNA as compared with the control sample. The analysis also shows that all three samples contained levels of RNA comparable with a TRα2 protein. The expression of the TRβ gene is unaffected in brain RNA from the TRα1 −/− mice (A.Mansén and B.Vennström, data not shown), suggesting that a compensatory increase in receptor expression does not occur. Hormonal status TH production in the thyroid gland is induced by the pituitary thyroid stimulating hormone (TSH). Here, the ligand-bound receptor acts as a negative regulator, particularly on the TSHβ chain gene, although effects on the α gene have also been observed. The role of TRα, if any, in the regulation of TH production via the pituitary was therefore first analyzed by determining the concentrations of free T3 and T4 in serum, an assay method that accurately reflects the availability of TH to an organism. The results (Figure 2A) show that the TRα-deficient male mice had lower levels of free T4 than control animals: 8.5 ± 1.7 versus 12.5 ± 4.3 pmol/l (p 0.01). Histological analyses of the thyroid glands of the TRα −/− mice showed no abnormalities, and no goitre has been detected in any animals during an 18 month observation period (data not shown). We conclude that the hypothyroidism in the TRα1 −/− mice is a result of dysregulated TSHα production. Figure 2.Analysis of the pituitary–thyroid axis of thyroid hormone production. (A) and (B) show the levels of free T3 and T4 in serum. (C) is a Northern blot analysis of RNAs for TSHα and β, respectively. The serum from 2½-month-old animals was used to determine levels of free T3 and T4 using a commercially available direct competitive radioimmunoassay from Amersham. To detect TSH RNAs, pituitaries from four animals, aged 8 weeks, were pooled and polyadenylated RNA was transferred to filters as described for Figure 1. Hybridization was done with cDNA probes specific for mouse TSHα and β, respectively (Gurr et al., 1984). The RNAs were quantified with a Phosphorimager, and the ratio of RNA levels between wt and TRα1 −/− animals was normalized against the hybridization signal obtained with a probe for G3PDH. (D) shows serum levels of TSH in 5-month-old male mice, as determined by a radioimmunoassay. Download figure Download PowerPoint Cardiac function Hyperthyroidism is usually associated with an elevated heart rate (tachycardia). To determine if TRα1 was involved in regulation of heart rate, a telemetry system involving radio transmitters with sensors that record heart rate and complete electrocardiograms in freely moving animals was implanted into 2-month-old male mice (Johansson and Thorén, 1997). As shown in Figure 3A, the TRα1-deficient mice have a lower mean heart rate (bradycardia) than control animals of the same genetic background (mean value per 24 h is 515 beats/min, as compared with 632 beats/min for the wt controls). Since the TRα1−/− mice had subnormal free T4 levels that could have resulted in the low heart rate, the mice were made hyperthyroid. Daily injections of 1 mg/kg body weight of T3 resulted in an increase in heart rate in the −/− and +/+ animals (Figure 3A). The TRα1 −/− mice failed to reach the same heart rate as the control group, even after prolonged treatment of hormone. The concentrations of free T3 in serum were the same in both sets of animals at the termination of the experiments, ranging from 30 to 80 pmol/l when measured 1 day after the last injection. Results similar to these were also obtained after injection of one-tenth and one-quarter of the amount of T3 above (data not shown). The data suggest that ablation of TRα1 expression results in a lower intrinsic heart rate, regardless of TH status. Figure 3.Cardiac and metabolic function abormalities. (A) is a telemetry recording of heart rate in TRα1 deficient and wild-type mice. The diagram shows 24 h mean values. After 48 h of baseline registration, T3 (1 mg/kg body weight) was injected 1 p.m. for 4 consecutive days. The data are from nine wild-type and eight −/− animals. (B) shows a typical example of an averaged ECG registration from a TRα1 deficient and a wild-type mouse. (C) shows the body temperature of mice as 24 h mean values, recorded with the telemetry system. Download figure Download PowerPoint Averaged electrocardiograms (ECG) recorded from TRα1 −/− and control animals were compared to provide an understanding of the bradycardia. Figure 3B shows that the TRα1 −/− mice have prolonged QRS- and QTend-durations, also after correction for the difference in heart rate. Table I reveals that particularly the QTend duration is markedly prolonged in the homozygotes, as compared with control mice. The prolonged QTend duration suggests a slow ventricular repolarization in the myocardium. Table 1. Different time intervals (ms) in the baseline ECG complex in homozygote TRα1 −/− mice (n=5) compared with wild-type mice (n=7). 24 h mean values are shown of body temperature (presented as SEM p 50 families with GRTH. Patients with a lack of TRβ expression display high TH and TSH levels and a loss of hearing (Refetoff et al., 1967; Forrest et al., 1996a, b). GRTH patients with the transdominant-negative version of the receptor often have elevated levels of TH, growth and mental retardation and tachycardia. Their TSH levels are surprisingly normal, resulting from the inability of the mutant receptor to downregulate the TSH genes. Taken together, these results suggest that TRβ has important roles in cells of neuronal and neuroendocrine origin. Only one indication of a specific role for TRα1 has emerged from the studies of GRTH patients. The combination of tachycardia and elevated TH levels in patients carrying a transdominant-negative version of TRβ is compatible with the absence of the mutant TRβ but the presence of TRα expression in the cardiac tissue that regulates heart rate. Our study identifies specific functions for TRα1, namely in regulation of the pacemaker function and in ventricular repolarization. The TRα1 −/− mice thus provide a unique model for identification of TH regulation of ion currents in isolated cardiac pacemaker and contractile cells. The data also suggest that searches for TH agonists or antagonists for use in treating cardiac dysfunction should be targeted towards TRα1. The fact that no patients with mutant TRα genes have been found had resulted in the hypothesis that TRα1 was indispensable. However, our data demonstrate the contrary: the mice are fertile, do not exhibit any gross deficiencies and appear to be only mildly hypothyroid. At first hand, it is puzzling that no patients with defective TRα genes have been found. However, our data raise the possibility that patients with defective TRα1 genes could have subnormal levels of TH and TSH which would contrast with the hallmarks of GRTH. The analysis of the TRα1 −/− mice potentially offers important clues to the identification of patients with mutant TRα genes. Materials and methods Targeting vector We designed a targeting strategy that would ablate only TRα1 expression and leave that of TRα2 intact. The two proteins arise from alternative splicing which generates proteins with different carboxy termini (Figure 1A). TRα1 is encoded by exons 1–9, whereas TRα2 results from alternative splicing from a donor site present 128 bp after the start of exon 9 (here referred to as exon 9a) to an acceptor site for exon 10. This alternative splicing event replaces the 40 C-termial amino acids encoded by TRα1 with 120 amino acids specific for TRα2. A targeted disruption of any of the exons 1–9a would consequently ablate both receptor variants, whereas deletion of nucleotides in exon 9, which are after the splice site (here referred to as exon 9b), would selectively disrupt TRα1. However, the orphan hormone receptor rev-erbAα is encoded by the opposite strand of the TRα locus and its last coding exon overlaps exon 10 of the TRα locus (Figure 1A). Therefore, the targeting construct was designed as shown in Figure 1A so that (i) the coding sequence s